Search
Showing results for "1"
News & Events
Sports star awardWe are proud to have so many very talented children and youth in our T1D community.
News & Events
Meet LaurelLeading international diabetes technology expert Laurel Messer visited Perth to share her experiences with closed loop systems at the Children’s Diabetes Centre’s Community Forum on March 28.
Does eating cashew nut spreads in the first year of life reduce the chances a baby will develop a cashew nut food allergy?
News & Events
PCH takes lead in Diabetes In Schools programPerth Children’s Hospital will be one of the first hospitals in Australia to deliver critical diabetes training to teachers and school staff as part of a new national Diabetes in Schools program.
News & Events
ENDIA milestoneThe ENDIA study — Australia’s largest study into the causes of Type 1 Diabetes— reached a significant milestone when it recruited its 700th patient in Perth.
Research
Resilience and Diabetes 2 (the RAD2 study)Investigators: Anna Hunt, Ashleigh Lin Stress and anxiety are significant problems in children and adolescence with type 1 diabetes. Not only do
News & Events
Perth's active T1D communityDespite the unseasonal weather, good turnouts were recorded for recent events organised by PMH and Diabetes WA.
Research
Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADMitophagy preserves overall mitochondrial fitness by selectively targeting damaged mitochondria for degradation. The regulatory mechanisms that prevent PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin (PINK1/Parkin)-dependent mitophagy and other selective autophagy pathways from overreacting while ensuring swift progression once initiated are largely elusive.
Research
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEThe pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment response versus placebo in peanut-allergic toddlers aged 1 through 3 years.
News & Events
Teaching Kitchensthe Teaching Kitchens program will start again on Thursday March 9 from 5-7pm, running for four weeks (every thursday evening).